Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy
Identifieur interne : 003295 ( Pmc/Checkpoint ); précédent : 003294; suivant : 003296Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy
Auteurs : T. Peter Kingham [États-Unis] ; Katherine S. Panageas [États-Unis] ; Charlotte E. Ariyan [États-Unis] ; Klaus J. Busam [États-Unis] ; Mary Sue Brady [États-Unis] ; Daniel G. Coit [États-Unis]Source :
- Annals of surgical oncology [ 1068-9265 ] ; 2010.
Abstract
Completion lymph node dissection (CLND), although considered a standard approach for patients with melanoma and a positive sentinel lymph node (SLN), is not performed in as many as 50% of indicated cases. This study evaluates the outcome of patients who had a positive SLN but did not undergo CLND at Memorial Sloan-Kettering Cancer Center.
A prospective database was used to identify all patients with a positive SLN from 1992 to 2008. Patient and tumor characteristics, number of positive SLNs, recurrence pattern, reason for not performing a CLND, and current status were evaluated.
There were 2269 patients who underwent SLN biopsy. Three hundred thirteen had a positive SLN, of whom 271 (87%) had a CLND and 42 (13%) did not. Patients in the no-CLND group were older (median age 70 vs. 56 years,
It remains unclear whether CLND must be performed in all melanoma patients with a positive SLN. For selected informed patients who choose not to participate in the Multicenter Selective Lymphadenectomy Trial II trial, or in centers where the trial is not available, nodal observation may be an acceptable option.
Url:
DOI: 10.1245/s10434-009-0836-3
PubMed: 19924486
PubMed Central: 4581428
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:4581428Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy</title>
<author><name sortKey="Kingham, T Peter" sort="Kingham, T Peter" uniqKey="Kingham T" first="T. Peter" last="Kingham">T. Peter Kingham</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Panageas, Katherine S" sort="Panageas, Katherine S" uniqKey="Panageas K" first="Katherine S." last="Panageas">Katherine S. Panageas</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ariyan, Charlotte E" sort="Ariyan, Charlotte E" uniqKey="Ariyan C" first="Charlotte E." last="Ariyan">Charlotte E. Ariyan</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Busam, Klaus J" sort="Busam, Klaus J" uniqKey="Busam K" first="Klaus J." last="Busam">Klaus J. Busam</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Brady, Mary Sue" sort="Brady, Mary Sue" uniqKey="Brady M" first="Mary Sue" last="Brady">Mary Sue Brady</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Coit, Daniel G" sort="Coit, Daniel G" uniqKey="Coit D" first="Daniel G." last="Coit">Daniel G. Coit</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">19924486</idno>
<idno type="pmc">4581428</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581428</idno>
<idno type="RBID">PMC:4581428</idno>
<idno type="doi">10.1245/s10434-009-0836-3</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">003968</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003968</idno>
<idno type="wicri:Area/Pmc/Curation">003967</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003967</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003295</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003295</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy</title>
<author><name sortKey="Kingham, T Peter" sort="Kingham, T Peter" uniqKey="Kingham T" first="T. Peter" last="Kingham">T. Peter Kingham</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Panageas, Katherine S" sort="Panageas, Katherine S" uniqKey="Panageas K" first="Katherine S." last="Panageas">Katherine S. Panageas</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ariyan, Charlotte E" sort="Ariyan, Charlotte E" uniqKey="Ariyan C" first="Charlotte E." last="Ariyan">Charlotte E. Ariyan</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Busam, Klaus J" sort="Busam, Klaus J" uniqKey="Busam K" first="Klaus J." last="Busam">Klaus J. Busam</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Brady, Mary Sue" sort="Brady, Mary Sue" uniqKey="Brady M" first="Mary Sue" last="Brady">Mary Sue Brady</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Coit, Daniel G" sort="Coit, Daniel G" uniqKey="Coit D" first="Daniel G." last="Coit">Daniel G. Coit</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of surgical oncology</title>
<idno type="ISSN">1068-9265</idno>
<idno type="eISSN">1534-4681</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">Completion lymph node dissection (CLND), although considered a standard approach for patients with melanoma and a positive sentinel lymph node (SLN), is not performed in as many as 50% of indicated cases. This study evaluates the outcome of patients who had a positive SLN but did not undergo CLND at Memorial Sloan-Kettering Cancer Center.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A prospective database was used to identify all patients with a positive SLN from 1992 to 2008. Patient and tumor characteristics, number of positive SLNs, recurrence pattern, reason for not performing a CLND, and current status were evaluated.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">There were 2269 patients who underwent SLN biopsy. Three hundred thirteen had a positive SLN, of whom 271 (87%) had a CLND and 42 (13%) did not. Patients in the no-CLND group were older (median age 70 vs. 56 years, <italic>P</italic>
< .01), and had a trend toward thicker melanomas (3.5 vs. 2.8 mm, <italic>P</italic>
< .06). A significantly higher percentage of no- CLND patients had lower-extremity melanomas (40% vs. 13% CLND; <italic>P</italic>
< .01). The most common reason for not performing a CLND was patient refusal (45%). There were similar rates and patterns of recurrence between the two groups. Recurrence-free survival and disease-specific survival were also similar between the groups.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">It remains unclear whether CLND must be performed in all melanoma patients with a positive SLN. For selected informed patients who choose not to participate in the Multicenter Selective Lymphadenectomy Trial II trial, or in centers where the trial is not available, nodal observation may be an acceptable option.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9420840</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8578</journal-id>
<journal-id journal-id-type="nlm-ta">Ann Surg Oncol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Surg. Oncol.</journal-id>
<journal-title-group><journal-title>Annals of surgical oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1068-9265</issn>
<issn pub-type="epub">1534-4681</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">19924486</article-id>
<article-id pub-id-type="pmc">4581428</article-id>
<article-id pub-id-type="doi">10.1245/s10434-009-0836-3</article-id>
<article-id pub-id-type="manuscript">NIHMS479689</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kingham</surname>
<given-names>T. Peter</given-names>
</name>
<degrees>MD</degrees>
<email>kinghamt@mskcc.org</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Panageas</surname>
<given-names>Katherine S.</given-names>
</name>
<degrees>DrPH</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Ariyan</surname>
<given-names>Charlotte E.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Busam</surname>
<given-names>Klaus J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Brady</surname>
<given-names>Mary Sue</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Coit</surname>
<given-names>Daniel G.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY</aff>
<aff id="A2"><label>2</label>
Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY</aff>
<aff id="A3"><label>3</label>
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY</aff>
<pub-date pub-type="nihms-submitted"><day>13</day>
<month>8</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub"><month>2</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>24</day>
<month>9</month>
<year>2015</year>
</pub-date>
<volume>17</volume>
<issue>2</issue>
<fpage>514</fpage>
<lpage>520</lpage>
<pmc-comment>elocation-id from pubmed: 10.1245/s10434-009-0836-3</pmc-comment>
<abstract><sec id="S1"><title>Background</title>
<p id="P1">Completion lymph node dissection (CLND), although considered a standard approach for patients with melanoma and a positive sentinel lymph node (SLN), is not performed in as many as 50% of indicated cases. This study evaluates the outcome of patients who had a positive SLN but did not undergo CLND at Memorial Sloan-Kettering Cancer Center.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A prospective database was used to identify all patients with a positive SLN from 1992 to 2008. Patient and tumor characteristics, number of positive SLNs, recurrence pattern, reason for not performing a CLND, and current status were evaluated.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">There were 2269 patients who underwent SLN biopsy. Three hundred thirteen had a positive SLN, of whom 271 (87%) had a CLND and 42 (13%) did not. Patients in the no-CLND group were older (median age 70 vs. 56 years, <italic>P</italic>
< .01), and had a trend toward thicker melanomas (3.5 vs. 2.8 mm, <italic>P</italic>
< .06). A significantly higher percentage of no- CLND patients had lower-extremity melanomas (40% vs. 13% CLND; <italic>P</italic>
< .01). The most common reason for not performing a CLND was patient refusal (45%). There were similar rates and patterns of recurrence between the two groups. Recurrence-free survival and disease-specific survival were also similar between the groups.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">It remains unclear whether CLND must be performed in all melanoma patients with a positive SLN. For selected informed patients who choose not to participate in the Multicenter Selective Lymphadenectomy Trial II trial, or in centers where the trial is not available, nodal observation may be an acceptable option.</p>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>État de New York</li>
</region>
</list>
<tree><country name="États-Unis"><region name="État de New York"><name sortKey="Kingham, T Peter" sort="Kingham, T Peter" uniqKey="Kingham T" first="T. Peter" last="Kingham">T. Peter Kingham</name>
</region>
<name sortKey="Ariyan, Charlotte E" sort="Ariyan, Charlotte E" uniqKey="Ariyan C" first="Charlotte E." last="Ariyan">Charlotte E. Ariyan</name>
<name sortKey="Brady, Mary Sue" sort="Brady, Mary Sue" uniqKey="Brady M" first="Mary Sue" last="Brady">Mary Sue Brady</name>
<name sortKey="Busam, Klaus J" sort="Busam, Klaus J" uniqKey="Busam K" first="Klaus J." last="Busam">Klaus J. Busam</name>
<name sortKey="Coit, Daniel G" sort="Coit, Daniel G" uniqKey="Coit D" first="Daniel G." last="Coit">Daniel G. Coit</name>
<name sortKey="Panageas, Katherine S" sort="Panageas, Katherine S" uniqKey="Panageas K" first="Katherine S." last="Panageas">Katherine S. Panageas</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003295 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 003295 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:4581428 |texte= Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:19924486" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |